shigella

志贺氏菌
  • 文章类型: Journal Article
    背景:本研究的目的是研究质粒介导的喹诺酮耐药(PMQR)基因的存在和生物膜的形成在几种对喹诺酮耐药的临床志贺氏菌分离株。
    方法:本横断面研究(2020年11月至2021年12月)收集了150名腹泻患者(10岁以下)的粪便样本。在Hektoen肠琼脂和木糖赖氨酸脱氧胆酸盐琼脂上培养样品后,标准微生物学测试,VITEK2系统,和聚合酶链反应(PCR)用于鉴定志贺氏菌分离株。肉汤微量稀释法用于确定抗生素敏感性。PMQR基因包括qnrA,qnrB,qnrC,qnrD,qnrE,qnrS,qnrVC,qepA,OQXAB,aac(6\')-Ib-cr,并通过PCR和微量滴定板法研究了耐喹诺酮类药物分离株的CRPP和生物膜形成,分别。使用肠细菌重复基因间共有聚合酶链反应(ERIC-PCR)技术确定喹诺酮耐药分离株的克隆相关性。
    结果:共有95株志贺氏菌分离株,包括S.sonnei(53,55.8%),S、flexneri(39,41.1%),和鲍迪氏链球菌(3,3.2%)被鉴定。分离株对氨苄青霉素的耐药率最高(92.6%,n=88/95)。总的来说,95个分离株中的42个(44.2%)同时对两种或更多种喹诺酮类药物具有抗性,包括26个(61.9%)S.sonnei和16个(38.1%)flexneri。所有分离株均具有多重耐药(对3种以上抗生素耐药)。PMQR基因的发生如下:qnrS(52.4%),qnrA和ac(6')-Ib-cr(33.3%),和qnrB(19.0%)。物种患病率如下:61.5%和37.5%(qnrS),19.2%和56.3%(qnrA),38.5%和25.0(ac(6')-Ib-cr),桑内和福内分别为19.2%和18.8%(qnrB),分别。未检测到其他PMQR基因。总的来说,52.8%(28/53)的喹诺酮敏感株和64.3%(27/42)的喹诺酮耐药株是生物膜生产者。喹诺酮耐药和喹诺酮敏感分离株之间的生物膜形成没有显着差异(P值=0.299)。根据ERIC-PCR,耐喹诺酮类药物的分离株表现出很高的遗传多样性。
    结论:似乎qnrS,qnrA,aac(6')-Ib-cr在本地区志贺氏菌分离株的喹诺酮耐药中起重要作用。此外,耐喹诺酮的福氏杆菌和松内分离株具有很高的遗传多样性。因此,抗生素治疗需要根据监测结果进行常规修订.
    BACKGROUND: The purpose of this study was to look into the presence of plasmid-mediated quinolone resistance (PMQR) genes and biofilm formation in several species of clinical Shigella isolates that were resistant to quinolones.
    METHODS: The stool samples of 150 patients (younger than 10 years) with diarrhea were collected in this cross-sectional study (November 2020 to December 2021). After cultivation of samples on Hektoen Enteric agar and xylose lysine deoxycholate agar, standard microbiology tests, VITEK 2 system, and polymerase chain reaction (PCR) were utilized to identify Shigella isolates. The broth microdilution method was used to determine antibiotic susceptibility. PMQR genes including qnrA, qnrB, qnrC, qnrD, qnrE, qnrS, qnrVC, qepA, oqxAB, aac(6\')-Ib-cr, and crpP and biofilm formation were investigated in quinolone-resistant isolates by PCR and microtiter plate method, respectively. An enterobacterial repetitive intergenic consensus polymerase chain reaction (ERIC-PCR) technique was used to determine the clonal relatedness of quinolone-resistant isolates.
    RESULTS: A total of 95 Shigella isolates including S. sonnei (53, 55.8%), S. flexneri (39, 41.1%), and S. boydii (3, 3.2%) were identified. The highest resistance rates of the isolates were against ampicillin (92.6%, n = 88/95). Overall, 42 of 95 (44.2%) isolates were simultaneously resistant against two or more quinolones including 26 (61.9%) S. sonnei and 16 (38.1%) S. flexneri. All isolates were multidrug-resistant (resistance to more than 3 antibiotics). The occurrence of PMQR genes was as follows: qnrS (52.4%), qnrA and aac(6\')-Ib-cr (33.3%), and qnrB (19.0%). The prevalence in species was as follows: 61.5% and 37.5% (qnrS), 19.2% and 56.3% (qnrA), 38.5% and 25.0 (aac(6\')-Ib-cr), and 19.2% and 18.8% (qnrB) for S. sonnei and S. flexneri, respectively. The other PMQR genes were not detected. In total, 52.8% (28/53) of quinolone-susceptible and 64.3% (27/42) of quinolone-resistant isolates were biofilm producers. Biofilm formation was not significantly different between quinolone-resistant and quinolone-susceptible isolates (P-value = 0.299). Quinolone-resistant isolates showed a high genetic diversity according to the ERIC-PCR.
    CONCLUSIONS: It seems that qnrS, qnrA, and aac(6\')-Ib-cr play a significant role in the quinolone resistance among Shigella isolates in our region. Also the quinolone-resistant S. flexneri and S. sonnei isolates had a high genetic diversity. Hence, antibiotic therapy needs to be routinely revised based on the surveillance findings.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    志贺氏菌物种由于其在腹泻疾病中的作用而对全球健康产生重大影响。2019-2022年对马什哈德儿科患者432份粪便样本进行的横断面研究,伊朗,鉴定了志贺氏菌属。并通过圆盘扩散法测试了它们对12种抗菌剂的敏感性。毒力因子的存在,即ipaH,virA,stx1和stx2,以及质粒介导的喹诺酮耐药(PMQR)基因,包括qnrA,qnrB,qnrC,qnrD,和qnrS,是通过利用聚合酶链反应技术确定的。对gyrA和parC基因的喹诺酮耐药决定区(QRDR)内检测到的15个分离株进行测序,表明氟喹诺酮(FQ)耐药。19.2%(83/432)的粪便样本含有志贺氏菌,主要是S.sonnei(77.1%),其次是福尔内尼(21.6%)和博伊迪(1.2%)。大多数分离株来自5岁以下儿童(55.4%)。所有菌株都有ipaH基因,缺少stx1和stx2,86.7%有virA。氨苄青霉素和四环素的耐药性较高(各84.3%),甲氧苄啶-磺胺甲恶唑(81.9%),和阿奇霉素(60.2%)。87.1%的分离株为多重耐药(MDR)。最常见的PMQR基因是qnrA和qnrS(各41%)。qnrD基因,在36.1%的病例中普遍存在,这是伊朗首次报道。最常见的PMQR谱是qnrADS(15.7%)。对萘啶酸和环丙沙星的耐药率分别为45.8%和12%,分别。志贺氏菌分离株在gyrA(密码子83、87和211)和parC(密码子80、84、93、126、128、129和132)基因中显示出突变。志贺氏菌分离株中gyrA基因的D87Y突变最为常见,发生在73%的病例中。parC基因中的F93S和L132T突变是本研究特有的。MDR志贺氏菌感染患者的经验性FQ治疗,在gyrA和parC的QRDR中拥有PMQR决定簇和/或突变,可能会增加继发疾病的风险,延长治疗持续时间,治疗失败,和阻力蔓延。因此,持续监测和基因检测以检测耐FQ志贺氏菌菌株的必要性至关重要.
    Shigella species significantly impact global health due to their role in diarrheal diseases. A 2019-2022 cross-sectional study on 432 stool samples from pediatric patients in Mashhad, Iran, identified Shigella spp. and tested their susceptibility to 12 antimicrobials by the disk diffusion method. The presence of virulence factors, namely ipaH, virA, stx1, and stx2, as well as plasmid-mediated quinolone resistance (PMQR) genes, including qnrA, qnrB, qnrC, qnrD, and qnrS, were ascertained through the utilization of polymerase chain reaction techniques. Sequencing of 15 isolates detected mutations within quinolone resistance-determining regions (QRDRs) at the gyrA and parC genes, indicating fluoroquinolone (FQ) resistance. 19.2 % (83/432) of stool samples contained Shigella, primarily S. sonnei (77.1 %), followed by S. flexneri (21.6 %) and S. boydii (1.2 %). Most isolates were from children under five (55.4 %). All strains had the ipaH gene, lacked stx1 and stx2, and 86.7 % had virA. High resistance was noted for ampicillin and tetracycline (84.3 % each), trimethoprim-sulfamethoxazole (81.9 %), and azithromycin (60.2 %). 87.1 % of isolates were multidrug-resistant (MDR). The most common PMQR genes were qnrA and qnrS (41 % each). The qnrD gene, prevalent in 36.1 % of cases, is reported in Iran for the first time. The most common PMQR profile was qnrADS (15.7 %). Resistance to nalidixic acid and ciprofloxacin was 45.8 % and 12 %, respectively. The Shigella isolates exhibited mutations in the gyrA (at codons 83, 87, and 211) and parC (at codons 80, 84, 93, 126, 128, 129, and 132) genes. The D87Y mutation in the gyrA gene was the most common in Shigella isolates, occurring in 73 % of cases. The F93S and L132T mutations in the parC gene were unique to this study. Empirical FQ therapy in patients infected with MDR Shigella, possessing PMQR determinants and/or mutations in the QRDRs of gyrA and parC, may escalate the risks of secondary diseases, extended treatment duration, therapeutic failure, and resistance spread. Consequently, the necessity for continuous surveillance and genetic testing to detect FQ-resistant Shigella strains is of paramount importance.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    在2017年至2019年之间,脉冲场凝胶电泳被全基因组测序(WGS)取代,以鉴定加拿大的肠道疾病簇。单核细胞增生李斯特菌的所有簇的数量和特征,沙门氏菌,产志贺毒素的大肠杆菌(STEC),和志贺氏菌属。分析了2015年至2021年之间的情况。在过渡到WGS之后,沙门氏菌数量的增加,STEC,注意到志贺氏菌簇,而单核细胞增生李斯特菌的簇数量减少。与以前的子类型方法不同,WGS提供了更高的分辨率来识别肠炎沙门氏菌的离散簇。这导致了一些与冷冻生面包屑鸡肉产品相关的疫情爆发,并最终改变了食品安全政策,以减少与这些产品相关的疾病数量。其他病原体检测到的暴发数量没有类似的增加。尽管WGS确实提高了对病例和分离株遗传相关性的信心,在收集流行病学数据以将这些疾病与共同来源联系起来方面仍然存在挑战。
    Between 2017 and 2019, pulsed-field gel electrophoresis was replaced by whole genome sequencing (WGS) for identifying enteric disease clusters in Canada. The number and characteristics of all clusters of Listeria monocytogenes, Salmonella, Shiga toxin-producing Escherichia coli (STEC), and Shigella spp. between 2015 and 2021 were analyzed. Following the transition to WGS, an increase in the number of Salmonella, STEC, and Shigella clusters was noted, whereas the number of clusters of L. monocytogenes decreased. Unlike previous subtyping methods, WGS provided increased resolution to identify discrete clusters of Salmonella Enteritidis. This led to the identification of a number of outbreaks linked to frozen raw breaded chicken products and ultimately a change in food safety policy to reduce the number of illnesses associated with these products. Other pathogens did not experience a similar increase in the number of outbreaks detected. Although WGS did provide increased confidence in the genetic relatedness of cases and isolates, challenges remained in collecting epidemiological data to link these illnesses to a common source.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    septin细胞骨架主要以在细胞分裂和宿主防御细菌感染中的作用而闻名。尽管最近的见解,septins在宿主防御中的作用尚不清楚。在巨噬细胞中,志贺氏菌诱导焦亡,一种促炎形式的细胞死亡,取决于质膜上的gasderminD(GSDMD)孔和膜破裂的细胞表面蛋白ninjurin-1(NINJ1)。这里,我们发现,septins促进脂多糖(LPS)/尼日利亚霉素和志贺氏菌感染诱导的巨噬细胞焦亡,但不影响细胞因子的表达或释放。我们观察到隔膜细丝在质膜处组装,并且GSDMD的裂解在隔膜耗尽的细胞中受损。我们发现septins调节线粒体动力学和NINJ1的表达。使用志贺氏菌-斑马鱼感染模型,我们表明,septin介导的焦亡是感染控制的体内机制。septins作为焦亡的介质的发现可能会激发创新的抗菌和抗炎治疗。
    The septin cytoskeleton is primarily known for roles in cell division and host defense against bacterial infection. Despite recent insights, the full breadth of roles for septins in host defense is poorly understood. In macrophages, Shigella induces pyroptosis, a pro-inflammatory form of cell death dependent upon gasdermin D (GSDMD) pores at the plasma membrane and cell surface protein ninjurin-1 (NINJ1) for membrane rupture. Here, we discover that septins promote macrophage pyroptosis induced by lipopolysaccharide (LPS)/nigericin and Shigella infection, but do not affect cytokine expression or release. We observe that septin filaments assemble at the plasma membrane, and cleavage of GSDMD is impaired in septin-depleted cells. We found that septins regulate mitochondrial dynamics and the expression of NINJ1. Using a Shigella-zebrafish infection model, we show that septin-mediated pyroptosis is an in vivo mechanism of infection control. The discovery of septins as a mediator of pyroptosis may inspire innovative anti-bacterial and anti-inflammatory treatments.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    志贺氏菌是全球中重度腹泻和低收入和中等收入国家儿童腹泻死亡的主要原因。目的我们调查了以色列志贺氏菌病和志贺氏菌的耐药性的趋势和特征。方法我们分析了基于前哨实验室的肠道病原体监测网络产生的数据,该网络系统地收集了前哨实验室的志贺氏菌检测数据。以及志贺氏菌国家参考实验室的分离株的特征。使用Joinpoint回归和中断时间序列分析评估志贺氏菌病发病率的趋势。结果以色列文化证实的志贺氏菌病的平均发病率从1998-2004年的每100,000人口114例(95%置信区间(CI):112-115)下降到2005-2011年的每100,000人口80例(95%CI:79-82)。这一比率在2012-2019年保持稳定,是美国或欧洲高收入国家报告的18-32倍。在COVID-19大流行期间降至最低值(2020年为19/100,000,2021年为5/100,000)之后,2022年,经培养证实的志贺氏菌病的发病率增加至每100,000人中39人.宋内志贺氏菌是最常见的血清群,负责传播的流行病的周期性发生,福氏志贺氏菌的比例有所下降。桑内对头孢曲松的同时耐药,氨苄西林和磺胺甲恶唑-甲氧苄啶从2020年的8.5%(34/402)增加到2022年的92.0%(801/876)。结论这些发现加强了对持续实验室监测的需求,并为以色列和其他地方性高收入国家或社区的志贺氏菌病的一级和二级预防策略提供了信息。
    BackgroundShigella is a leading cause of moderate-to-severe diarrhoea worldwide and diarrhoeal deaths in children in low- and-middle-income countries.AimWe investigated trends and characteristics of shigellosis and antimicrobial resistance of Shigella sonnei in Israel.MethodsWe analysed data generated by the Sentinel Laboratory-Based Surveillance Network for Enteric Pathogens that systematically collects data on detection of Shigella at sentinel laboratories, along with the characterisation of the isolates at the Shigella National Reference Laboratory. Trends in the shigellosis incidence were assessed using Joinpoint regression and interrupted time-series analyses.ResultsThe average incidence of culture-confirmed shigellosis in Israel declined from 114 per 100,000 population (95% confidence interval (CI): 112-115) 1998-2004 to 80 per 100,000 population (95% CI: 79-82) 2005-2011. This rate remained stable 2012-2019, being 18-32 times higher than that reported from the United States or European high-income countries. After decreasing to its lowest values during the COVID-19 pandemic years (19/100,000 in 2020 and 5/100,000 in 2021), the incidence of culture-confirmed shigellosis increased to 39 per 100,000 population in 2022. Shigella sonnei is the most common serogroup, responsible for a cyclic occurrence of propagated epidemics, and the proportion of Shigella flexneri has decreased. Simultaneous resistance of S. sonnei to ceftriaxone, ampicillin and sulphamethoxazole-trimethoprim increased from 8.5% (34/402) in 2020 to 92.0% (801/876) in 2022.ConclusionsThese findings reinforce the need for continuous laboratory-based surveillance and inform the primary and secondary prevention strategies for shigellosis in Israel and other endemic high-income countries or communities.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    食源性疾病,由食品中的有害微生物引起的,是一个重大的全球健康问题。目前用于鉴定这些病原体的方法既费力又耗时。在这项研究中,我们设计了一种快速,精确的检测技术,该技术使用重组酶聚合酶扩增结合侧流试纸(RPA-LFD)对肉类中发现的三种食源性病原体进行检测。通过使用专用的检测设备,RPA-LFD允许快速分析大肠杆菌O157的DNA(E.大肠杆菌O157),沙门氏菌,和食物中禁止的志贺氏菌病原体。大肠杆菌O157、沙门氏菌、志贺氏菌为0.168fg/μl(1.04CFU/ml),0.72fg/μl(27.49CFU/ml),和1.25fg/μl(48.84CFU/ml),分别。这种方法提供了一个短的检测窗口,在低温下运行,遵循简单的程序,并表现出高灵敏度。我们的研究建立了同时鉴定三种食源性致病菌核酸的RPA-LFD方法,提供快速识别多种污染物的有效解决方案。
    Foodborne illnesses, caused by harmful microorganisms in food, are a significant global health issue. Current methods for identifying these pathogens are both labor-intensive and time-consuming. In this research, we devised a swift and precise detection technique using recombinase polymerase amplification combined with a lateral flow dipstick (RPA-LFD) for three foodborne pathogens found in meat. By employing a dedicated detection device, RPA-LFD allows for the rapid analysis of DNA from Escherichia coli O157 (E. coli O157), Salmonella, and Shigella-pathogens that are prohibited in food. The detection thresholds for E. coli O157, Salmonella, and Shigella are 0.168 fg/μl (1.04 CFU/ml), 0.72 fg/μl (27.49 CFU/ml), and 1.25 fg/μl (48.84 CFU/ml), respectively. This method provides a short detection window, operates at low temperatures, follows simple procedures, and exhibits high sensitivity. Our study establishes the RPA-LFD method for simultaneously identifying the nucleic acid of three foodborne pathogens, offering an efficient solution for quickly identifying multiple contaminants.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    目的:当前的研究旨在调查WolaitaSodo镇Kalte河的理化和细菌学质量状况,埃塞俄比亚南部。
    方法:使用无菌玻璃瓶从三个不同的河流站点收集了总共42个水样:Damota(上游),Kera(中游),和Gututo(下游)。检查所有水样是否存在异养细菌,总大肠菌群和粪大肠菌群采用直接平板计数法和膜过滤法。美国水务协会建议的标准方法用于分析水样的理化参数。
    结果:结果显示,总大肠菌群,粪便大肠杆菌计数范围为8.9至12.6×104cfu/ml,7.5-11.3×102cfu/ml和5.7-9.7×104cfu/ml,分别。细菌计数结果表明,河水超过了WHO推荐的饮用水限值。大肠杆菌,铜绿假单胞菌,金黄色葡萄球菌,沙门氏菌,志贺氏菌属是从河水样品中分离出的常见细菌病原体。理化分析结果表明,一些参数生物需氧量(BOD),化学需氧量(COD),浊度超过世卫组织的最大允许限值,其他参数低于世卫组织的允许限值。
    结论:因此,细菌病原体的存在,粪便大肠菌群指标,Kalte河的一些物理化学参数超过建议的限值可能会使河水的使用者面临感染的风险。
    OBJECTIVE: The current research aimed to investigate the physicochemical and bacteriological quality status of the Kalte River in Wolaita Sodo Town, southern Ethiopia.
    METHODS: A total of 42 water samples were collected using sterile glass bottles from three different river sites: Damota (upstream), Kera (midstream), and Gututo (downstream). All the water samples were examined for the presence of heterotrophic bacteria, total coliform and fecal coliform using direct plate count method and membrane filtration method. Standard methods suggested by American water works association were used to analysis the physicochemical parameters of the water samples.
    RESULTS: The results revealed that the total heterotrophic bacteria, total coliform, and fecal coliform count ranged from 8.9 to 12.6 × 104 cfu/ml, 7.5-11.3 × 102 cfu/ml and 5.7-9.7 × 104 cfu/ml, respectively. The bacterial count results indicated that the river water crossed the WHO-recommended limit of potable water. Escherichia coli, Pseudomonas aeruginosa, Staphylococcus aureus, Salmonella, and Shigella species were the common bacterial pathogens isolated from river water samples. The results of the physicochemical analysis revealed that some of the parameters Biological Oxygen Demand (BOD), Chemical Oxygen Demand (COD), and turbidity exceeded the maximum permissible limits of WHO and other parameters were below the WHO permissible limits.
    CONCLUSIONS: Therefore, the presence of bacterial pathogens, fecal coliform indicators, and some physicochemical parameters of the Kalte River exceeding the recommended limits may expose users of the river water to the risk of infection.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    细胞内人病原体志贺氏菌侵入结肠上皮引起疾病。在入侵之前,这种细菌在人体内的不同环境中导航,包括胃和小肠.为了适应不断变化的环境,志贺氏菌利用细菌第二信使c-di-GMP信号系统,由编码GGDEF结构域的二鸟苷酸环化酶(DGC)合成。福氏志贺氏菌在其基因组中编码总共9个GGDEF或GGDEF-EAL结构域酶,但是这些基因中有5种已经获得了突变,这些突变可能使这些酶的c-di-GMP合成活性失活。在这项研究中,我们研究了个别福氏链球菌DGC在c-di-GMP合成和发病机制中的作用。我们在福氏链球菌菌株中分别表达了4个完整的DGC中的每一个,其中这4个DGC已被缺失(Δ4DGC)。我们发现4种福氏杆菌完整的DGC在体外和组织培养细胞感染过程中以不同水平合成c-di-GMP。我们还发现dgcF和dgcI的表达显着降低了侵袭和斑块形成,和dgcF表达增加酸敏感性,并且这些表型与测量的c-di-GMP水平不一致。然而,删除这4个DGC并不能消除福氏链球菌c-di-GMP,我们发现dgcE,dgcQ,和dgcN,它们在GGDEF结构域之前都有无义突变,仍然生产c-di-GMP。这些福氏链球菌简并DGC假基因表达为多种蛋白质,与基因内的多个起始密码子一致。我们认为完整和简并的DGC都有助于福氏链球菌c-di-GMP信号传导。
    The intracellular human pathogen Shigella invades the colonic epithelium to cause disease. Prior to invasion, this bacterium navigates through different environments within the human body, including the stomach and the small intestine. To adapt to changing environments, Shigella uses the bacterial second messenger cyclic di-GMP (c di-GMP) signaling system, synthesized by diguanylate cyclases (DGCs) encoding GGDEF domains. Shigella flexneri encodes a total of 9 GGDEF or GGDEF-EAL domain enzymes in its genome, but five of these genes have acquired mutations that presumably inactivated the c-di-GMP synthesis activity of these enzymes. In this study, we examined individual S. flexneri DGCs for their role in c-di-GMP synthesis and pathogenesis. We individually expressed each of the four intact DGCs in a S. flexneri strain, where these four DGCs had been deleted (Δ4DGC). We found that the 4 S. flexneri intact DGCs synthesize c-di-GMP at different levels in vitro and during infection of tissue-cultured cells. We also found that dgcF and dgcI expression significantly reduces invasion and plaque formation, and dgcF expression increases acid sensitivity, and that these phenotypes did not correspond with measured c-di-GMP levels. However, deletion of these four DGCs did not eliminate S. flexneri c-di-GMP, and we found that dgcE, dgcQ, and dgcN, which all have nonsense mutations prior to the GGDEF domain, still produce c-di-GMP. These S. flexneri degenerate DGC pseudogenes are expressed as multiple proteins, consistent with multiple start codons within the gene. We propose that both intact and degenerate DGCs contribute to S. flexneri c-di-GMP signaling.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    志贺氏菌属。感染对全球疾病负担有重要贡献,主要影响发展中国家的幼儿。目前,没有FDA批准的针对志贺氏菌的疫苗,抗生素耐药性的患病率正在增加,使治疗选择有限。减毒活疫苗株WRSs2(S.sonnei)和WRSf2G12(S.flexneri2a)具有高度免疫原性,使它们成为有前途的疫苗候选物,但在其脂多糖(LPS;也称为内毒素)上具有炎性脂质A结构。这里,我们利用细菌酶组合化学(BECC)在WRSs2和WRSf2G12及其各自的野生型菌株中异位表达脂质A修饰酶,在志贺氏菌背景中产生靶向的脂质A修饰。脂质A的去磷酸化,而不是去酰化,在体外减少LPS诱导的TLR4信号传导,在体内抑制内毒素作用。这些BECC修饰的疫苗株保留了其亲本株的表型性状,如上皮细胞的侵袭和小鼠的免疫原性,没有不利的内毒素。总的来说,我们的观察结果表明,BECC工程减毒活疫苗是一种有希望的安全有效的志贺氏菌疫苗方法.
    Shigella spp. infection contributes significantly to the global disease burden, primarily affecting young children in developing countries. Currently, there are no FDA-approved vaccines against Shigella, and the prevalence of antibiotic resistance is increasing, making therapeutic options limited. Live-attenuated vaccine strains WRSs2 (S. sonnei) and WRSf2G12 (S. flexneri 2a) are highly immunogenic, making them promising vaccine candidates, but possess an inflammatory lipid A structure on their lipopolysaccharide (LPS; also known as endotoxin). Here, we utilized bacterial enzymatic combinatorial chemistry (BECC) to ectopically express lipid A modifying enzymes in WRSs2 and WRSf2G12, as well as their respective wild-type strains, generating targeted lipid A modifications across the Shigella backgrounds. Dephosphorylation of lipid A, rather than deacylation, reduced LPS-induced TLR4 signaling in vitro and dampened endotoxic effects in vivo. These BECC-modified vaccine strains retained the phenotypic traits of their parental strains, such as invasion of epithelial cells and immunogenicity in mice without adverse endotoxicity. Overall, our observations suggest that BECC-engineered live attenuated vaccines are a promising approach to safe and effective Shigella vaccines.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    背景。本系统评价和荟萃分析的目的是估计感染弯曲杆菌的个体的比例。埃希氏菌,沙门氏菌,志贺氏菌,或耶尔森氏菌会发展为反应性关节炎。方法。进行了系统的审查,包含2024年1月之前发表的英语文章,来自Embase,PubMed,Scopus,和WebofScience数据库。这篇综述包括观察性研究,这些研究报告了弯曲杆菌患者反应性关节炎(ReA)的发生,埃希氏菌,沙门氏菌,志贺氏菌,或耶尔森氏菌感染。数据提取由两名审阅者独立进行。随后,进行了随机效应荟萃分析,使用I2值评估异质性。此外,采用meta回归分析研究水平变量对观察到的异质性的潜在影响。结果。共确定了87项研究;23项报道了弯曲杆菌感染后的ReA发展,7例大肠杆菌感染后的ReA报告,30例报告沙门氏菌病后出现ReA,14在志贺氏菌病后报告了ReA,13例报告了耶尔森氏菌感染后的ReA。出现ReA的弯曲杆菌患者比例为0.03(95%CI[0.01,0.06],I2=97.62%);发生ReA的大肠埃希菌患者比例为0.01(95%CI[0.00,0.06],I2=92.78%);沙门氏菌患者比例为0.04(95%CI[0.02,0.08],I2=97.67%);志贺氏菌患者比例为0.01(95%CI[0.01,0.03],I2=90.64%);发生ReA的耶尔森氏菌患者比例为0.05(95%CI[0.02,0.13],I2=96%)。结论。沙门氏菌的比例很大,志贺氏菌,耶尔森氏菌病例导致了ReA。尽管如此,由于研究之间存在显著的异质性,因此谨慎解释研究结果非常重要.
    Background. The objective of this systematic review and meta-analysis was to estimate the proportions of individuals infected with Campylobacter, Escherichia, Salmonella, Shigella, or Yersinia who develop reactive arthritis. Methods. A systematic review was conducted, encompassing English-language articles published before January 2024, sourced from the Embase, PubMed, Scopus, and Web of Science databases. This review included observational studies that reported the occurrence of reactive arthritis (ReA) among patients with Campylobacter, Escherichia, Salmonella, Shigella, or Yersinia infections. Data extraction was carried out independently by two reviewers. Subsequently, a random-effects meta-analysis was performed, with heterogeneity assessed using the I2 value. Additionally, meta-regression was employed to investigate the potential influence of study-level variables on the observed heterogeneity. Results. A total of 87 studies were identified; 23 reported on ReA development after Campylobacter infection, 7 reported on ReA after Escherichia infection, 30 reported ReA onset after salmonellosis, 14 reported ReA after shigellosis, and 13 reported ReA after Yersinia infection. The proportion of Campylobacter patients who developed ReA was 0.03 (95% CI [0.01, 0.06], I2 = 97.62%); the proportion of Escherichia patients who developed ReA was 0.01 (95% CI [0.00, 0.06], I2 = 92.78%); the proportion of Salmonella patients was 0.04 (95% CI [0.02, 0.08], I2 = 97.67%); the proportion of Shigella patients was 0.01 (95% CI [0.01, 0.03], I2 = 90.64%); and the proportion of Yersinia patients who developed ReA was 0.05 (95% CI [0.02, 0.13], I2 = 96%). Conclusion. A significant proportion of Salmonella, Shigella, and Yersinia cases resulted in ReA. Nonetheless, it is important to interpret the findings cautiously due to the substantial heterogeneity observed between studies.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

公众号